Oncotarget

Research Papers:

Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization

André Steven, Sandra Leisz, Katharina Sychra, Bernhard Hiebl, Claudia Wickenhauser, Dimitrios Mougiakakos, Rolf Kiessling, Carsten Denkert and Barbara Seliger _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:52061-52084. https://doi.org/10.18632/oncotarget.10474

Metrics: PDF 2458 views  |   HTML 3040 views  |   ?  


Abstract

André Steven1, Sandra Leisz1, Katharina Sychra6, Bernhard Hiebl2, Claudia Wickenhauser3, Dimitrios Mougiakakos4, Rolf Kiessling5, Carsten Denkert6, Barbara Seliger1

1Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany

2Centre for Basic Medical Research, Martin Luther University Halle-Wittenberg, Halle, Germany

3Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany

4Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany

5Karolinska Institutet, CCK, Stockholm, Sweden

6Charité, Institute of Pathology, Berlin, Germany

Correspondence to:

Barbara Seliger, email: [email protected]

Keywords: CREB, HER-2/neu, hypoxia, angiogenesis, mitochondria

Received: March 11, 2016     Accepted: June 17, 2016     Published: July 7, 2016

ABSTRACT

The cAMP-responsive element-binding protein (CREB) is involved in the tumorigenicity of HER-2/neu-overexpressing murine and human tumor cells, but a link between the HER-2/neu-mediated CREB activation, its posttranslational modification and localization and changes in the cellular metabolism, due to an altered (tumor) microenvironment remains to be established. The present study demonstrated that shRNA-mediated silencing of CREB in HER-2/neu-transformed cells resulted in decreased tumor formation, which was associated with reduced angiogenesis, but increased necrotic and hypoxic areas in the tumor. Hypoxia induced pCREBSer133, but not pCREBSer121 expression in HER-2/neu-transformed cells. This was accompanied by upregulation of the hypoxia-inducible genes GLUT1 and VEGF, increased cell migration and matrix metalloproteinase-mediated invasion. Treatment of HER-2/neu+ cells with signal transduction inhibitors targeting in particular HER-2/neu was able to revert hypoxia-controlled CREB activation. In addition to changes in the phosphorylation, hypoxic response of HER-2/neu+ cells caused a transient ubiquitination and SUMOylation as well as a co-localization of nuclear CREB to the mitochondrial matrix. A mitochondrial localization of CREB was also demonstrated in hypoxic areas of HER-2/neu+ mammary carcinoma lesions. This was accompanied by an altered gene expression pattern, activity and metabolism of mitochondria leading to an increased respiratory rate, oxidative phosphorylation and mitochondrial membrane potential and consequently to an enhanced apoptosis and reduced cell viability. These data suggest that the HER-2/neu-mediated CREB activation caused by a hypoxic tumor microenvironment contributes to the neoplastic phenotype of HER-2/neu+ cells at various levels.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10474